{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:54:31Z","timestamp":1787237671877,"version":"build-2736575974"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Endocr Disord"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy among young women. Insulin resistance is a key feature in the pathogenesis of PCOS; also high molecular weight adiponectin is a marker of insulin resistance. The aim of this study was to evaluate the insulin resistance, metabolic and androgenic profiles and high molecular weight adiponectin in obese and non-obese PCOS patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this cross-sectional study in outpatient endocrinology clinics of Shiraz University of Medical Sciences, 80 women aged 17\u201343\u2009years old with PCOS were enrolled. Biochemical and hormonal assay was done on fasting blood sample on the third day of follicular phase.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The individuals had a mean age of 28.39\u2009\u00b1\u20096.56\u2009years, mean weight of 65.41\u2009\u00b1\u200912.59 Kg, mean BMI of 25.5\u2009\u00b1\u20094.9, and mean waist circumference of 88.0\u2009\u00b1\u200913.1\u2009cm. Of all individuals 20% had frank insulin resistance with HOMA-IR\u2009&gt;\u20093.8. Although the obese PCOS patients had lower levels of high molecular weight adiponectin (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.03) than the normal weight PCOS individuals, the level of insulin and insulin resistance was not different in them (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.13, 0.13). Patients with classic PCOS phenotype significantly had higher levels of insulin resistance and free androgen index (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0\n                      <jats:bold>&lt;<\/jats:bold>\n                      \u00a00.001, 0.001). We found a significant correlation between the insulin level and free androgen index (correlation coefficient: 0.266 and\n                      <jats:italic>P<\/jats:italic>\n                      \u2009=\u20090.018) after adjusting for BMI.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This cross-sectional study showed a high incidence of insulin resistance in PCOS patients independent of obesity, and determined BMI related lower level of high molecular weight adiponectin in obese PCOS individuals. More detailed studies are warranted for evaluation of insulin resistance and its pathophysiologic role in PCOS.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12902-021-00710-z","type":"journal-article","created":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T04:03:37Z","timestamp":1615262617000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":44,"title":["Insulin resistance and high molecular weight adiponectin in obese and non-obese patients with Polycystic Ovarian Syndrome (PCOS)"],"prefix":"10.1186","volume":"21","author":[{"given":"Farnaz Kamali Haghighi","family":"Shirazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zohre","family":"Khodamoradi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4998-6918","authenticated-orcid":false,"given":"Marjan","family":"Jeddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,9]]},"reference":[{"issue":"1","key":"710_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40618-016-0523-8","volume":"40","author":"K Polak","year":"2017","unstructured":"Polak K, Czyzyk A, Simoncini T, Meczekalski B. New markers of insulin resistance in polycystic ovary syndrome. J Endocrinol Investig. 2017;40(1):1\u20138.","journal-title":"J Endocrinol Investig"},{"key":"710_CR2","first-page":"377","volume-title":"Polycystic ovary syndrome","author":"J Zawadzki","year":"1992","unstructured":"Zawadzki J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. In: Dunaif A, Givens HR, Haseltine FP, Merriam GR, editors. Polycystic ovary syndrome. Boston: Blackwell Scientific; 1992. p. 377\u201384."},{"issue":"11","key":"710_CR3","doi-asserted-by":"publisher","first-page":"4237","DOI":"10.1210\/jc.2006-0178","volume":"91","author":"R Azziz","year":"2006","unstructured":"Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, et al. Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an androgen excess society guideline. J Clin Endocrinol Metab. 2006;91(11):4237\u201345.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"710_CR4","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","volume":"81","author":"E Rotterdam","year":"2004","unstructured":"Rotterdam E, Group A-SPCW. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19.","journal-title":"Fertil Steril"},{"issue":"1","key":"710_CR5","first-page":"157","volume":"33","author":"M Ebrahimi-Mamaghani","year":"2015","unstructured":"Ebrahimi-Mamaghani M, Saghafi-Asl M, Pirouzpanah S, Aliasgharzadeh A, Aliashrafi S, Rezayi N, et al. Association of insulin resistance with lipid profile, metabolic syndrome, and hormonal aberrations in overweight or obese women with polycystic ovary syndrome. J Health Popul Nutr. 2015;33(1):157.","journal-title":"J Health Popul Nutr"},{"issue":"4","key":"710_CR6","first-page":"490","volume":"9","author":"Z Zahiri","year":"2016","unstructured":"Zahiri Z, Sharami SH, Milani F, Mohammadi F, Kazemnejad E, Ebrahimi H, et al. Metabolic syndrome in patients with polycystic ovary syndrome in Iran. Int J Fertil Steril. 2016;9(4):490\u20136.","journal-title":"Int J Fertil Steril"},{"key":"710_CR7","doi-asserted-by":"crossref","unstructured":"Rojas J, Ch\u00e1vez M, Olivar L, Rojas M, Morillo J, Mej\u00edas J, et al. Polycystic ovary syndrome, insulin resistance, and obesity: navigating the pathophysiologic labyrinth. Int J Reprod Med. 2014;2014:719050.","DOI":"10.1155\/2014\/719050"},{"key":"710_CR8","doi-asserted-by":"crossref","unstructured":"Glueck CJ, Goldenberg N. Characteristics of obesity in polycystic ovary syndrome: etiology, treatment, and genetics. Metabolism. 2019;92:108\u201320.","DOI":"10.1016\/j.metabol.2018.11.002"},{"issue":"1","key":"710_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s12958-016-0173-x","volume":"14","author":"V De Leo","year":"2016","unstructured":"De Leo V, Musacchio MC, Cappelli V, Massaro MG, Morgante G, Petraglia F. Genetic, hormonal and metabolic aspects of PCOS: an update. Reprod Biol Endocrinol. 2016;14(1):38.","journal-title":"Reprod Biol Endocrinol"},{"key":"710_CR10","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cca.2019.11.003","volume":"502","author":"X Zeng","year":"2020","unstructured":"Zeng X, Xie YJ, Liu YT, Long SL, Mo ZC. Polycystic ovarian syndrome: correlation between hyperandrogenism, insulin resistance and obesity. Clin Chim Acta. 2020;502:214\u201321.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"710_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.29252\/ijrm.14.4.263","volume":"14","author":"P Layegh","year":"2016","unstructured":"Layegh P, Mousavi Z, Tehrani DF, Parizadeh SMR, Khajedaluee M. Insulin resistance and endocrine-metabolic abnormalities in polycystic ovarian syndrome: comparison between obese and non-obese PCOS patients. Int J Reprod Biomed. 2016;14(4):263.","journal-title":"Int J Reprod Biomed"},{"issue":"4","key":"710_CR12","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/13813455.2018.1518987","volume":"126","author":"DM Bannigida","year":"2020","unstructured":"Bannigida DM, Nayak SB. R V. serum visfatin and adiponectin - markers in women with polycystic ovarian syndrome. Arch Physiol Biochem. 2020;126(4):283\u20136.","journal-title":"Arch Physiol Biochem"},{"issue":"3","key":"710_CR13","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1210\/jc.2009-1557","volume":"95","author":"A O'Connor","year":"2010","unstructured":"O'Connor A, Phelan N, Tun TK, Boran G, Gibney J, Roche HM. High-molecular-weight adiponectin is selectively reduced in women with polycystic ovary syndrome independent of body mass index and severity of insulin resistance. J Clin Endocrinol Metab. 2010;95(3):1378\u201385.","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"710_CR14","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1080\/09513590.2018.1534096","volume":"35","author":"DP Baldani","year":"2019","unstructured":"Baldani DP, Skrgatic L, Kasum M, Zlopasa G, Kralik Oguic S, Herman M. Altered leptin, adiponectin, resistin and ghrelin secretion may represent an intrinsic polycystic ovary syndrome abnormality. Gynecol Endocrinol. 2019;35(5):401\u20135.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"710_CR15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.3109\/09513590.2014.984676","volume":"31","author":"CI Chen","year":"2015","unstructured":"Chen CI, Hsu MI, Lin SH, Chang YC, Hsu CS, Tzeng CR. Adiponectin and leptin in overweight\/obese and lean women with polycystic ovary syndrome. Gynecol Endocrinol. 2015;31(4):264\u20138.","journal-title":"Gynecol Endocrinol"},{"issue":"6","key":"710_CR16","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.fertnstert.2010.02.014","volume":"94","author":"E Guastella","year":"2010","unstructured":"Guastella E, Longo RA, Carmina E. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes. Fertil Steril. 2010;94(6):2197\u2013201.","journal-title":"Fertil Steril"},{"key":"710_CR17","doi-asserted-by":"publisher","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","volume":"26","author":"JF Ascaso","year":"2003","unstructured":"Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care. 2003;26:3320\u20135.","journal-title":"Diabetes Care"},{"issue":"11","key":"710_CR18","doi-asserted-by":"publisher","first-page":"4071","DOI":"10.1210\/en.2015-1159","volume":"156","author":"A Hurliman","year":"2015","unstructured":"Hurliman A, Keller Brown J, Maille N, Mandala M, Casson P, Osol G. Hyperandrogenism and insulin resistance, not changes in body weight, mediate the development of endothelial dysfunction in a female rat model of polycystic ovary syndrome (PCOS). Endocrinology. 2015;156(11):4071\u201380.","journal-title":"Endocrinology."},{"issue":"11","key":"710_CR19","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1093\/humrep\/dew243","volume":"31","author":"S Cassar","year":"2016","unstructured":"Cassar S, Misso ML, Hopkins WG, Shaw CS, Teede HJ, Stepto NK. Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic\u2013hyperinsulinaemic clamp studies. Hum Reprod. 2016;31(11):2619\u201331.","journal-title":"Hum Reprod"},{"issue":"7","key":"710_CR20","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1038\/s41366-019-0318-z","volume":"43","author":"E Koivuaho","year":"2019","unstructured":"Koivuaho E, Laru J, Ojaniemi M, Puukka K, Kettunen J, Tapanainen J, et al. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood\u2014longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int J Obes. 2019;43(7):1370\u20139.","journal-title":"Int J Obes"},{"issue":"12","key":"710_CR21","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1080\/09513590.2019.1640200","volume":"35","author":"AD Genazzani","year":"2019","unstructured":"Genazzani AD, Prati A, Marchini F, Petrillo T, Napolitano A, Simoncini T. Differential insulin response to oral glucose tolerance test (OGTT) in overweight\/obese polycystic ovary syndrome patients undergoing to myo-inositol (MYO), alpha lipoic acid (ALA), or combination of both. Gynecol Endocrinol. 2019;35(12):1088\u201393.","journal-title":"Gynecol Endocrinol"},{"issue":"4","key":"710_CR22","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40520-018-0993-y","volume":"31","author":"A Ghachem","year":"2019","unstructured":"Ghachem A, Lagac\u00e9 J-C, Brochu M, Dionne IJ. Fat-free mass and glucose homeostasis: is greater fat-free mass an independent predictor of insulin resistance? Aging Clin Exp Res. 2019;31(4):447\u201354.","journal-title":"Aging Clin Exp Res"},{"issue":"11","key":"710_CR23","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.2337\/dc11-1032","volume":"34","author":"CG Lee","year":"2011","unstructured":"Lee CG, Boyko EJ, Barrett-Connor E, Miljkovic I, Hoffman AR, Everson-Rose SA, et al. Insulin sensitizers may attenuate lean mass loss in older men with diabetes. Diabetes Care. 2011;34(11):2381\u20136.","journal-title":"Diabetes Care"},{"issue":"7","key":"710_CR24","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.apjtm.2015.07.001","volume":"8","author":"B Shan","year":"2015","unstructured":"Shan B, Cai J-h, Yang S-Y, Li Z-R. Risk factors of polycystic ovarian syndrome among Li people. Asian Pac J Trop Med. 2015;8(7):590\u20133.","journal-title":"Asian Pac J Trop Med"},{"issue":"5","key":"710_CR25","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1111\/cen.13808","volume":"89","author":"S Shorakae","year":"2018","unstructured":"Shorakae S, Ranasinha S, Abell S, Lambert G, Lambert E, de Courten B, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol. 2018;89(5):628\u201333.","journal-title":"Clin Endocrinol"},{"issue":"5","key":"710_CR26","doi-asserted-by":"publisher","first-page":"R219","DOI":"10.1530\/REP-14-0435","volume":"149","author":"PM Spritzer","year":"2015","unstructured":"Spritzer PM, Lecke SB, Satler F, Morsch DM. Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome. Reproduction. 2015;149(5):R219\u2013R27.","journal-title":"Reproduction."},{"issue":"9","key":"710_CR27","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/ijo.2017.126","volume":"41","author":"A Couto Alves","year":"2017","unstructured":"Couto Alves A, Valcarcel B, M\u00e4kinen VP, Morin-Papunen L, Sebert S, Kangas AJ, et al. Metabolic profiling of polycystic ovary syndrome reveals interactions with abdominal obesity. Int J Obes. 2017;41(9):1331\u201340.","journal-title":"Int J Obes"},{"issue":"10","key":"710_CR28","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1507\/endocrj.EJ14-0186","volume":"61","author":"J Jia","year":"2014","unstructured":"Jia J, Bai J, Liu Y, Yin J, Yang P, Yu S, et al. Association between retinol-binding protein 4 and polycystic ovary syndrome: a meta-analysis. Endocr J. 2014;61(10):995\u20131002.","journal-title":"Endocr J"},{"issue":"2","key":"710_CR29","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1002\/ijgo.12527","volume":"142","author":"MH Daghestani","year":"2018","unstructured":"Daghestani MH. Evaluation of biochemical, endocrine, and metabolic biomarkers for the early diagnosis of polycystic ovary syndrome among non-obese Saudi women. Int J Gynaecol Obstet. 2018;142(2):162\u20139.","journal-title":"Int J Gynaecol Obstet"},{"issue":"11","key":"710_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1080\/09513590.2017.1342165","volume":"33","author":"AR Pande","year":"2017","unstructured":"Pande AR, Guleria AK, Singh SD, Shukla M, Dabadghao P. Beta cell function and insulin resistance in lean cases with polycystic ovary syndrome. Gynecol Endocrinol. 2017;33(11):877\u201381.","journal-title":"Gynecol Endocrinol"},{"issue":"2","key":"710_CR31","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s40200-018-0371-5","volume":"17","author":"S Toosy","year":"2018","unstructured":"Toosy S, Sodi R, Pappachan JM. Lean polycystic ovary syndrome (PCOS): an evidence-based practical approach. J Diabetes Metab Disord. 2018;17(2):277\u201385.","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"710_CR32","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/humrep\/del466","volume":"22","author":"K-M Seow","year":"2007","unstructured":"Seow K-M, Juan C-C, Hsu Y-P, Hwang J-L, Huang L-W. Low-Tone Ho Amelioration of insulin resistance in women with PCOS via reduced insulin receptor substrate-1 Ser312 phosphorylation following laparoscopic ovarian electrocautery. Hum Reprod. 2007;22(4):1003\u201310.","journal-title":"Hum Reprod"},{"issue":"4","key":"710_CR33","doi-asserted-by":"publisher","first-page":"E628","DOI":"10.1210\/jc.2012-3908","volume":"98","author":"P Moghetti","year":"2013","unstructured":"Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman J-M, et al. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome. J Clin Endocrinol Metab. 2013;98(4):E628\u2013E37.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"710_CR34","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1111\/cen.12406","volume":"81","author":"F Hosseinpanah","year":"2014","unstructured":"Hosseinpanah F, Barzin M, Keihani S, Ramezani Tehrani F, Azizi F. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study. Clin Endocrinol. 2014;81(1):93\u20139.","journal-title":"Clin Endocrinol"},{"issue":"6","key":"710_CR35","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2337\/dc05-1801","volume":"29","author":"K Hara","year":"2006","unstructured":"Hara K, Horikoshi M, Yamauchi T, Yago H, Miyazaki O, Ebinuma H, Imai Y, Nagai R, Kadowaki T. Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome. Diabetes Care. 2006;29(6):1357\u201362.","journal-title":"Diabetes Care"},{"issue":"18","key":"710_CR36","doi-asserted-by":"publisher","first-page":"18073","DOI":"10.1074\/jbc.M414231200","volume":"280","author":"A Xu","year":"2005","unstructured":"Xu A, Chan KW, Hoo RL, Wang Y, Tan KC, Zhang J, et al. Testosterone selectively reduces the high molecular weight form of adiponectin by inhibiting its secretion from adipocytes. J Biol Chem. 2005;280(18):18073\u201380.","journal-title":"J Biol Chem"},{"issue":"2","key":"710_CR37","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.metabol.2009.12.010","volume":"60","author":"GS Merki-Feld","year":"2011","unstructured":"Merki-Feld GS, Imthurn B, Rosselli M, Spanaus K. Serum concentrations of high-molecular weight adiponectin and their association with sex steroids in premenopausal women. Metabolism. 2011;60(2):180\u20135.","journal-title":"Metabolism."}],"container-title":["BMC Endocrine Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00710-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12902-021-00710-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12902-021-00710-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T04:06:08Z","timestamp":1615262768000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcendocrdisord.biomedcentral.com\/articles\/10.1186\/s12902-021-00710-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["710"],"URL":"https:\/\/doi.org\/10.1186\/s12902-021-00710-z","relation":{},"ISSN":["1472-6823"],"issn-type":[{"value":"1472-6823","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,9]]},"assertion":[{"value":"24 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The Ethics Committee of the Shiraz University of Medical Science approved this study (IR.SUMS.med. REC.1394.S39). The study protocol conformed to the ethical guidelines of the 1975 Helsinki Declaration. Written informed consent was obtained from the patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no competing interests to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"45"}}